Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01947166 · ClinicalTrials.gov registry record · NA

Pancreatic Resection, Malnutrition and Readmission

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
38
Enrollment target

NCT01947166 is a NA study that has completed, run by Duke University. The registered enrollment target is 38 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01947166, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
38 participants
Enrollment target

Study Summary

The Whipple procedure is associated with increased readmission rates for infection, pancreatic leak, and failure to thrive/malnutrition. The purpose of this study is to develop an evidence based perioperative nutrition plan to improve patient outcomes. The study has two specific aims including evaluation of feasibility of implementing an evidence based perioperative nutritional plan for patients undergoing Whipple and evaluation of impact of a standard perioperative nutritional plan on primary outcome of readmission rate and secondary outcomes of readmission cause, length of stay for initial hospitalization and/or readmission, post surgical complications (surgical site infections, pancreatic leak, sepsis, delayed gastric emptying), and nutritional status (PG-Subject Generated Assessment scores, BMI, albumin, pre-albumin, and method of oral intake). Categorical variables including readmission rate, readmission cause, post-surgical complications and nutritional status will be compared by chi-square test between intervention and control group. Length of stay for initial hospitalization and readmission will be compared by non parametric Wilcoxon test between two groups. Descriptive statistics will be used to describe the sample. There are no risks to the study participants.

Interventions

  • DIETARY_SUPPLEMENT Nestle Impact Advanced Recovery nutritional supplement

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2013-12
Est. Completion 2016-06
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT01947166

The ClinicalTrials.gov registry entry for NCT01947166 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Nestle Impact Advanced Recovery nutritional supplement is the first listed.

NCT01947166 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01947166 about?

NCT01947166 is a clinical study titled "Pancreatic Resection, Malnutrition and Readmission". The Whipple procedure is associated with increased readmission rates for infection, pancreatic leak, and failure to thrive/malnutrition. The purpose of this study is to develop an evidence based perioperative nutrition plan to improve patient outcomes. The study has two specific aims including evalu...

What is the current status of trial NCT01947166?

This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2013-12. Estimated completion is 2016-06.

What interventions are being tested in trial NCT01947166?

The interventions under investigation include: Nestle Impact Advanced Recovery nutritional supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01947166?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.